Glenmark Generic Blocked In Netherlands Over Early Launch
Novartis has convinced a Dutch court to stop Glenmark from making or selling a generic medication used to treat low blood platelet levels in the Netherlands after appearing to launch the...To view the full article, register now.
Already a subscriber? Click here to view full article